#nogapendekin_alfa_inbakicept

Nogapendekin alfa inbakicept

Medication

Nogapendekin alfa inbakicept, sold under the brand name Anktiva, is a fixed-dose combination medication used for the treatment of bladder cancer. It is an interleukin-15 receptor agonist. It is given in combination with Bacillus Calmette-Guérin via intravesical drug delivery. It contains nogapendekin alfa, a human IL-15N72D variant; and inbakicept, an interleukin 15 receptor subunit alpha.

Tue 6th

Provided by Wikipedia

Learn More

This keyword could refer to multiple things. Here are some suggestions:

0 searches
This keyword has never been searched before
This keyword has never been searched for with any other keyword.